Mark Boguski MD, PhD, Novartis Institutes for BioMedical Research (NIBR)
Case: Helicos Biosciences Corporation Presenter: Stanley N. Lapidus, President and CEO
Helicos BioSciences Corporation is developing instruments for high-speed sequencing of DNA or RNA without amplification. We achieve this by analyzing true single molecules. Our innovative technology will bring forth a new era of genomic medicine. Disease prevention, diagnosis and treatment will never be the same.
Panel:
Reid Leonard, External Scientific Affairs, Merck & Co
Guy Van Meter, Associate Director of Corporate Development, Dyax
DISCLAIMER: Our aim is to continuously provide our
progressive audience with an open and interactive medium to view
and share relevant,
beneficial and interesting "career, economic, lifestyle and
networking" listings, ads, content and resources.
While the above information may be accurate and viable, the role
of Minority Professional Network, Inc. (MPN) is
strictly as a communications medium, and we do not
accept any responsibility for
cancellation, changes, errors, omissions, inconveniences, or any other form
of liability for any content
displayed or disseminated via our web sites, or e-marketing or social media
promotional services.
If there are any
doubts, we
encourage you to conduct additional research or contact the listed host or responsible entity.
CLICK HERE to inform us about any ads, listings or content
which appear to be
inappropriate,
fraudulent or misleading, or inconsistent with our theme and focus.